Xian Aidewansi Medical Technology Co., Ltd. announced that it will receive CNY 74,440,700 in an equity round of funding on August 1, 2014. The company and the investors entered into a share transfer and investment agreement on the same date. The company will receive the funding in two stages. As part of the first stage, the company will receive CNY 33,440,700 in funding from new investor, Zhou Gongyao. As part of the funding, the company will receive CNY 3,000,000 in the form of a loan payment and the balance CNY 30,440,700 in the form of intellectual property rights. As part of the transaction, CNY 2,550,000 will be transferred to the registered capital and the balance CNY 27,890,700 will be transferred to its capital reserve. On completion of the first stage, the investor will hold 20.32% stake in the company. The registered capital of the company will increase from CNY 10,000,000 to CNY 12,550,000.

As part of the transaction, existing investor, Shaanxi Industrial Technology Research Institute will transfer 3,000,000 shares in the company. As part of the second stage, the transaction will include participation from new investors, Changchun High & New Technology Industries (Group) Inc., Jilin National Biological Industry Venture Capital Co., Ltd., and Beijing Galaxy Luckystar VC Company Limited for CNY 26,000,000, CNY 14,000,000, and CNY 1,000,000 respectively. As part of the transaction, the company will transfer CNY 13,670,000 in the registered capital and the balance CNY 27,330,000 to its capital reserve. On closing of the transaction, Changchun High & New Technology Industries (Group) Inc., Jilin National Biological Industry Venture Capital Co., Ltd., Qu Gongqi, Shaanxi Industrial Technology Research Institute, Zhou Gongyao, Zhang Qingwei, and Beijing Galaxy Luckystar VC Company Limited will hold 44.50%, 17.80%, 13.35%, 11.44%, 9.73%, 1.91%, and 1.27% respectively. On closing of the second stage, the registered capital of the company will increase from CNY 12,550,000 to CNY 26,220,000. The company reported total assets of CNY 9,058,968.78, net assets of CNY 8,557,962.08, total owners equity of CNY 8,557,962.08, revenues of CNY 101,183.50, and net loss of CNY 1,442,037.92 for the financial year ended December 31, 2013.

On August 20, 2014, the transaction was approved at the 21st meeting of 7th directorate of Changchun High & New Technology Industries (Group) Inc.